ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.217C>T (p.Arg73Trp)

gnomAD frequency: 0.00005  dbSNP: rs567357782
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000595106 SCV000704651 uncertain significance not provided 2016-12-14 criteria provided, single submitter clinical testing
Invitae RCV000803680 SCV000943562 uncertain significance Autosomal recessive polycystic kidney disease 2021-09-01 criteria provided, single submitter clinical testing This sequence change replaces arginine with tryptophan at codon 73 of the PKHD1 protein (p.Arg73Trp). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs567357782, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 499252). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV002483603 SCV002792352 uncertain significance Polycystic kidney disease 4 2022-01-25 criteria provided, single submitter clinical testing
Natera, Inc. RCV000803680 SCV001453464 uncertain significance Autosomal recessive polycystic kidney disease 2018-07-24 no assertion criteria provided clinical testing
Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center RCV001844838 SCV001876977 uncertain significance Autosomal dominant polycystic liver disease 2021-09-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.